DK0861081T3 - Anvendelse af epinastin til behandling af smerter - Google Patents

Anvendelse af epinastin til behandling af smerter

Info

Publication number
DK0861081T3
DK0861081T3 DK96939018T DK96939018T DK0861081T3 DK 0861081 T3 DK0861081 T3 DK 0861081T3 DK 96939018 T DK96939018 T DK 96939018T DK 96939018 T DK96939018 T DK 96939018T DK 0861081 T3 DK0861081 T3 DK 0861081T3
Authority
DK
Denmark
Prior art keywords
epinastine
pain
treatment
Prior art date
Application number
DK96939018T
Other languages
Danish (da)
English (en)
Inventor
Birgit Jung
John Montague Mead Christopher
Michel Pairet
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0861081T3 publication Critical patent/DK0861081T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK96939018T 1995-11-14 1996-11-13 Anvendelse af epinastin til behandling af smerter DK0861081T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19542281A DE19542281C2 (de) 1995-11-14 1995-11-14 Verwendung von Epinastin für die Behandlung der Migräne
PCT/EP1996/004957 WO1997017971A1 (de) 1995-11-14 1996-11-13 Verwendung von epinastin für die behandlung von schmerzen

Publications (1)

Publication Number Publication Date
DK0861081T3 true DK0861081T3 (da) 2002-05-27

Family

ID=7777343

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96939018T DK0861081T3 (da) 1995-11-14 1996-11-13 Anvendelse af epinastin til behandling af smerter

Country Status (32)

Country Link
US (1) US5942503A (et)
EP (1) EP0861081B1 (et)
JP (2) JP4264850B2 (et)
KR (1) KR100435611B1 (et)
CN (1) CN1104242C (et)
AR (1) AR004321A1 (et)
AT (1) ATE213160T1 (et)
AU (1) AU706112B2 (et)
BG (1) BG62511B1 (et)
BR (1) BR9611502A (et)
CA (1) CA2232008C (et)
CO (1) CO4770978A1 (et)
CZ (1) CZ290115B6 (et)
DE (2) DE19542281C2 (et)
DK (1) DK0861081T3 (et)
EE (1) EE03512B1 (et)
ES (1) ES2171746T3 (et)
HK (1) HK1015280A1 (et)
HU (1) HU225759B1 (et)
IL (1) IL123601A (et)
NO (1) NO982172L (et)
NZ (1) NZ322467A (et)
PL (1) PL186615B1 (et)
PT (1) PT861081E (et)
RO (1) RO118373B1 (et)
RU (2) RU2238733C2 (et)
SK (1) SK61398A3 (et)
TR (1) TR199800853T2 (et)
TW (1) TW575423B (et)
UY (1) UY24354A1 (et)
WO (1) WO1997017971A1 (et)
ZA (1) ZA969520B (et)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
ES2234324T3 (es) * 1998-11-02 2005-06-16 MERCK & CO., INC. Combinaciones de un agonista 5ht1b/1d y un inhibidor selectivo de cox-2 para el tratamiento de la migraña.
WO2000048583A2 (en) * 1999-02-19 2000-08-24 Pozen Inc. Formulation of 5-ht agonists with nsaids, especially cox-2 inhibitors, for treating migraine
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
JP2002087963A (ja) * 2000-09-08 2002-03-27 Nippon Boehringer Ingelheim Co Ltd 直接打錠により製造されたエピナスチン含有錠剤
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
JP4616009B2 (ja) 2002-12-26 2011-01-19 ポーゼン インコーポレイテッド ＮＳＡＩＤｓおよびトリプタンを含有する多層剤型
EP1452177A1 (en) * 2003-02-27 2004-09-01 Boehringer Ingelheim International GmbH Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent
WO2007007851A1 (en) * 2005-07-08 2007-01-18 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising epinastine
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
US8536445B2 (en) * 2006-06-02 2013-09-17 Emcore Solar Power, Inc. Inverted metamorphic multijunction solar cells
EP1875899A1 (en) * 2006-06-29 2008-01-09 Laboratorios Del Dr. Esteve, S.A. Use of 5HT7 receptor agonists for the treatment of pain
US20080102097A1 (en) * 2006-10-31 2008-05-01 Zanella John M Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
US8470360B2 (en) 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
RU2464984C2 (ru) * 2007-11-22 2012-10-27 Общество с ограниченной ответственностью "МС-Вита" Нестероидное противовоспалительное лекарственное средство
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US9610243B2 (en) 2008-04-18 2017-04-04 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20090264477A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc., An Indiana Corporation Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
US9132085B2 (en) * 2008-04-18 2015-09-15 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using clonidine and bupivacaine
US9072727B2 (en) * 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8629172B2 (en) * 2008-04-18 2014-01-14 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising clonidine
US9132119B2 (en) 2008-04-18 2015-09-15 Medtronic, Inc. Clonidine formulation in a polyorthoester carrier
US8946277B2 (en) 2008-04-18 2015-02-03 Warsaw Orthopedic, Inc. Clonidine formulations in a biodegradable polymer carrier
US8883768B2 (en) * 2008-04-18 2014-11-11 Warsaw Orthopedic, Inc. Fluocinolone implants to protect against undesirable bone and cartilage destruction
US20090264489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
US8722079B2 (en) * 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20090263489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
US20090263451A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
US20100098746A1 (en) * 2008-10-20 2010-04-22 Warsaw Orthopedic, Inc. Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
US8822546B2 (en) * 2008-12-01 2014-09-02 Medtronic, Inc. Flowable pharmaceutical depot
US20100228097A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Methods and compositions to diagnose pain
US20100239632A1 (en) * 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US8617583B2 (en) * 2009-07-17 2013-12-31 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
US8231891B2 (en) * 2009-07-31 2012-07-31 Warsaw Orthopedic, Inc. Implantable drug depot for weight control
US20110097375A1 (en) 2009-10-26 2011-04-28 Warsaw Orthopedic, Inc. Formulation for preventing or reducing bleeding at a surgical site
US9988445B2 (en) 2013-09-02 2018-06-05 The University Of Melbourne Method of treatment of pain by administration of a CCL17 specific antibody
CN105708840A (zh) * 2014-12-01 2016-06-29 重庆安格龙翔医药科技有限公司 一种盐酸依匹斯汀组合物
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR102041389B1 (ko) 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
WO2020212948A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung

Also Published As

Publication number Publication date
JP4850880B2 (ja) 2012-01-11
HK1015280A1 (en) 1999-10-15
EP0861081A1 (de) 1998-09-02
SK61398A3 (en) 1998-09-09
US5942503A (en) 1999-08-24
PL326653A1 (en) 1998-10-12
KR19990067527A (ko) 1999-08-25
PT861081E (pt) 2002-06-28
IL123601A (en) 2002-12-01
RU2217144C2 (ru) 2003-11-27
RU2238733C2 (ru) 2004-10-27
BR9611502A (pt) 1999-03-02
MX9803206A (es) 1998-09-30
NO982172D0 (no) 1998-05-13
BG62511B1 (bg) 2000-01-31
ES2171746T3 (es) 2002-09-16
EE03512B1 (et) 2001-10-15
HUP9903489A3 (en) 2001-12-28
KR100435611B1 (ko) 2005-01-13
ATE213160T1 (de) 2002-02-15
CN1104242C (zh) 2003-04-02
AU7623096A (en) 1997-06-05
HU225759B1 (en) 2007-08-28
RO118373B1 (ro) 2003-05-30
JP4264850B2 (ja) 2009-05-20
CA2232008A1 (en) 1997-05-22
EE9800158A (et) 1998-12-15
NO982172L (no) 1998-05-13
AU706112B2 (en) 1999-06-10
AR004321A1 (es) 1998-11-04
EP0861081B1 (de) 2002-02-13
CZ149898A3 (cs) 1998-10-14
WO1997017971A1 (de) 1997-05-22
BG102408A (en) 1998-12-30
HUP9903489A2 (hu) 2000-03-28
IL123601A0 (en) 1998-10-30
DE19542281C2 (de) 1997-12-04
ZA969520B (en) 1997-05-14
CN1202111A (zh) 1998-12-16
DE59608738D1 (de) 2002-03-21
CO4770978A1 (es) 1999-04-30
TW575423B (en) 2004-02-11
DE19542281A1 (de) 1997-05-15
NZ322467A (en) 2000-01-28
CZ290115B6 (cs) 2002-06-12
JP2000500446A (ja) 2000-01-18
TR199800853T2 (xx) 1998-09-21
PL186615B1 (pl) 2004-02-27
JP2009019050A (ja) 2009-01-29
CA2232008C (en) 2004-01-06
UY24354A1 (es) 2001-10-25

Similar Documents

Publication Publication Date Title
DK0861081T3 (da) Anvendelse af epinastin til behandling af smerter
DE69629343D1 (de) Spaziergängerstütze
DE19680452T1 (de) Massagegerät
DK0777457T3 (da) Anvendelse af glyceryltriacetat til behandling af onychomykoser
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO982562D0 (no) Sammensetning for behandling av smerte
DE29517727U1 (de) Massagegerät
DE59607418D1 (de) Haarbehandlungsmittel
DE29501987U1 (de) Saunaheizvorrichtung
DE29505809U1 (de) Unterarmgehstütze
KR960033582U (ko) 지압구
DE29509352U1 (de) Gesundastpflaster
MD940178A (ro) Carja
KR970008153U (ko) 지압구
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
KR970012149U (ko) 지압발판
DE29508031U1 (de) Massagegerät
KR970027099U (ko) 안마기
KR970012147U (ko) 팔찌용 지압구
KR970004277U (ko) 지압구
KR970012148U (ko) 지압구
DE29501471U1 (de) Orthopädische Einlage
KR960028346U (ko) 쑥뜸기
KR970023795U (ko) 질통
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia